文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

靶向 WD 重复蛋白 5(WDR5):药物化学视角。

Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective.

机构信息

Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.

Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

出版信息

J Med Chem. 2021 Aug 12;64(15):10537-10556. doi: 10.1021/acs.jmedchem.1c00037. Epub 2021 Jul 20.


DOI:10.1021/acs.jmedchem.1c00037
PMID:34283608
Abstract

WD repeat-containing protein 5 (WDR5) is a member of the WD40 protein family, and it is widely involved in various biological activities and not limited to epigenetic regulation . WDR5 is also involved in the initiation and development of many diseases and plays a key role in these diseases. Since WDR5 was discovered, it has been suggested as a potential disease treatment target, and a large number of inhibitors targeting WDR5 have been discovered. In this review, we discussed the development of inhibitors targeting WDR5 over the years, and the biological mechanisms of these inhibitors based on previous mechanistic studies were explored. Finally, we describe the development potential of inhibitors targeting WDR5 and prospects for further applications.

摘要

WD 重复蛋白 5(WDR5)是 WD40 蛋白家族的成员,广泛参与各种生物活性,不仅限于表观遗传调控。WDR5 还参与许多疾病的发生和发展,在这些疾病中起着关键作用。自 WDR5 被发现以来,它已被提议作为一种潜在的疾病治疗靶点,并且已经发现了大量针对 WDR5 的抑制剂。在这篇综述中,我们讨论了多年来针对 WDR5 的抑制剂的发展,并根据以前的机制研究探讨了这些抑制剂的生物学机制。最后,我们描述了针对 WDR5 的抑制剂的开发潜力和进一步应用的前景。

相似文献

[1]
Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective.

J Med Chem. 2021-8-12

[2]
Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core.

J Med Chem. 2020-1-7

[3]
Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models.

Proc Natl Acad Sci U S A. 2023-1-3

[4]
Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC Interaction.

ACS Chem Biol. 2023-1-20

[5]
Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders.

J Med Chem. 2021-8-12

[6]
HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.

Hepatology. 2020-5

[7]
Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction.

J Med Chem. 2023-6-22

[8]
The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein- Protein Interaction.

Curr Med Chem. 2020

[9]
Discovery of WD Repeat-Containing Protein 5 (WDR5)-MYC Inhibitors Using Fragment-Based Methods and Structure-Based Design.

J Med Chem. 2020-4-9

[10]
Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5.

Molecules. 2021-2-25

引用本文的文献

[1]
Participation of host cell proteins in inclusion bodies of non-segmented RNA virus infected cells: a molecular insight.

Virol J. 2025-8-18

[2]
Salvianolic acid A facilitates cartilage repair in knee osteoarthritis model rats by promoting WDR5 expression.

Regen Ther. 2025-3-12

[3]
NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression.

Adv Sci (Weinh). 2025-1

[4]
The NTE domain of PTENα/β promotes cancer progression by interacting with WDR5 via its SSSRRSS motif.

Cell Death Dis. 2024-5-14

[5]
Pocket Crafter: a 3D generative modeling based workflow for the rapid generation of hit molecules in drug discovery.

J Cheminform. 2024-3-21

[6]
Small molecule WDR5 inhibitors down-regulate lncRNA expression.

RSC Med Chem. 2024-1-10

[7]
Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors.

J Med Chem. 2023-12-28

[8]
Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer.

J Med Chem. 2023-12-14

[9]
Screening and optimization of phage display cyclic peptides against the WDR5 WBM site.

RSC Med Chem. 2023-8-17

[10]
Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5.

Cell Rep. 2023-9-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索